Referências

1. Korf, B.R., Neurofibromas and malignant tumors of the peripheral nerve sheath (1999) Neurofibromatosis. Phenotype, natural history and pathogenesis, pp. 142-161. , Baltmore and London: The Johns Hopkins University Press
2. Friedman, J.M., Riccardi, V.M., Clinical and epidemiological features (1999) Neurofibromatosis. Phenotype, natural history and pathogenesis, pp. 29-86. , Baltmore and London: The Johns Hopkins University Press
3. Kluwe, L., Friedrich, R.E., Mautner, V.F., Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas (1999) Cancer Genet Cytogenet, 113 (1), pp. 65-69
4. Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X., Lázaro, C., Confirmation of a double-hit model for the NF1 gene in benign neurofibromas (1997) Am J Hum Genet, 61 (3), pp. 512-519
5. Overdiek, A., Winner, U., Mayatepek, E., Rosenbaum, T., Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone (2008) Pediatr Res, 64 (1), pp. 40-43
6. Ansari, A., Nagamani, M., Pregnancy and neurofibromatosis (von Recklinghausen's disease) (1976) Obstet Gynecol, 47 (1), pp. 25S-29S
7. Dugoff, L., Sujansky, E., Neurofibromatosis type 1 and pregnancy (1996) Am J Med Genet, 66 (1), pp. 7-10
8. Huson, S.M., Harper, P.S., Compston, D.A.S., Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales (1988) Brain, 111 (6), pp. 1355-1381
9. Baker, V.V., Hatch, K.D., Shingleton, H.M., Neurofibrosarcoma complicating pregnancy (1989) Gynecol Oncol, 34 (2), pp. 237-239
10. Kellogg, A., Watson, W.J., Malignant Schwannoma in Pregnancy: A Case Report and Literature Review (2010) Am J Perinatol, 27 (3), pp. 201-204
11. Puls, L.E., Chandler, P.A., Malignant schwannoma in pregnancy (1991) Acta obstet Gynecol Scand, 70 (3), pp. 243-244
12. Posma, E., Aalbers, R., Kurniawan, Y.S., Essen, A.J.V., Peeters, P.M.J.G., Loon, A.J.V., Neurofibromatosis type I and pregnancy: a fatal attraction? Development of malignant schwannoma during pregnancy in a patient with neurofibromatosis type I (2003) BJOG, 110 (5), pp. 530-532
13. Scheithauer, B.W., Woodruff, J.M., Erlandson, R.A., Neurofibroma (1999) Tumors of the peripheral nervous system, pp. 177-218. , Whashington, DC: Amer Registry of Pathology
14. Enzinger, F.M., Weiss, S.W., (1995) Soft tissue tumors, , 3rd ed. St Louis: Mosby Inc
15. Rubinstein, L.J., Russell, D.S., (1989) Pathology of tumours of the nervous system, , 5th ed. London: Eduard Arnold
16. Gorlin, R.J., Cohen, M.M., Levin, L.S., Hamartoneoplastic Syndromes (1990) Syndromes of the Head and Neck, pp. 393-416. , Oxford: Oxford University Press
17. Fishbein, L., Zhang, X., Fisher, L.B., Li, H., Campbell-Thompson, M., Yachnis, A., Rubenstein, A., Wallace, M.R., In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells (2007) Mol Carcinog, 46 (7), pp. 512-523
18. Riccardi, V.M., von Recklinghausen neurofibromatosis (1981) N Eng J Med, 305 (27), pp. 1617-1627
19. Ducatman, B.S., Scheithauer, B.W., Piepgras, D.G., Reiman, H.M., Ilstrup, D.M., Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases (1986) Cancer, 57 (10), pp. 2006-2021
20. Carroll, S.L., Ratner, N., How does the Schwann cell lineage form tumors in NF1? (2008) Glia, 56 (14), pp. 1590-1605
21. Shen, M.H., Harper, P.S., Upadhyaya, M., Molecular genetics of neurofibromatosis type 1 (NF1) (1996) J Med Genet, 33 (1), pp. 2-17
22. Mattocks, C., Baralle, D., Tarpey, P., Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain (2004) J Med Genet, 41 (4), pp. e48
23. Daston, M.M., Scrable, H., Nordlund, M., Sturbaum, A.K., Nissen, L.M., Ratner, N., The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes (1992) Neuron, 8 (3), pp. 415-428
24. Ars, E., Serra, E., Garcia, J., Kruyer, H., Gaona, A., Lazaro, C., Estivill, X., Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 (2000) Hum Mol Genet, 9 (2), pp. 237-247
25. Kolch, W., Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions (2000) Biochem, 351 (2), pp. 289-305
26. Gottfried, O.N., Viskochil, D.H., Couldwell, W.T., Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications (2010) Neurosurg Focus, 28 (1), pp. E8
27. Bonneau, F., D'Angelo, I., Welti, S., Stier, G., Ylanne, J., Scheffzek, K., Expression, purification and preliminary crystallographic characterization of a novel segment from the neurofibromatosis type 1 protein (2004) Acta Crystallog D Biol Crystallog, 60 (12), pp. 2364-2367
28. Mousley, C.J., Tyeryar, K.R., Vincent-Pope, P., Bankaitis, V.A., The Sec14-superfamily and the regulatory interface between phospholipid metabolism and membrane trafficking (2007) Biochim Biophys Acta, 1771 (6), pp. 727-736
29. Le, L.Q., Parada, L.F., Tumor microenvironment and neurofibromatosis type I: connecting the GAPs (2007) Oncogene, 26 (32), pp. 4609-4616
30. Knudson, A.G., Mutation and cancer: statistical study of retinoblastoma (1971) Proc Natl Acad Sci U S A, 68 (4), pp. 820-823
31. Serra, E., Rosenbaum, T., Winner, U., Aledo, R., Ars, E., Estivill, X., Lenard, H.G., Lazaro, C., Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations (2000) Hum Mol Genet, 9 (20), pp. 3055-3064
32. Maertens, O., Brems, H., Vandesompele, J., De Raedt, T., Heyns, I., Rosenbaum, T., De Schepper, S., Janssens, S., Comprehensive NF1 screening on cultured Schwann cells from neurofibromas (2006) Hum Mutat, 27 (10), pp. 1030-1040
33. Kim, H.A., Rosenbaum, T., Marchionni, M.A., Ratner, N., DeClue, J.E., Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes (1995) Oncogene, 11 (2), pp. 325-335
34. Zhu, Y., Ghosh, P., Charnay, P., Burns, D.K., Parada, L.F., Neurofibromas in NF1: Schwann cell origin and role of tumor environment (2002) Science, 296 (5569), pp. 920-922
35. Ingram, D.A., Hiatt, K., King, A.J., Fisher, L., Shivakumar, R., Derstine, C., Wenning, M.J., Hood, A., Hyperactivation of p21ras and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro (2001) J Exp Med, 194 (1), pp. 57-69
36. Yang, F.C., Chen, S., Clegg, T., Li, X., Morgan, T., Estwick, S.A., Yuan, J., Travers, J., NF1+/-mast cells induce neurofibroma like phenotypes through secreted TGF-{beta} signaling (2006) Human Molecular Genet, 15 (16), pp. 2421-2437
37. Ingram, D.A., Yang, F.C., Travers, J.B., Wenning, M.J., Hiatt, K., New, S., Hood, A., Clapp, D.W., Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo (2000) J Exp Med, 191 (1), pp. 181-188
38. Kadono, T., Kikuchi, K., Nakagawa, H., Tamaki, K., Expressions of various growth factors and their receptors in tissues from neurofibroma (2000) Dermatology, 201 (1), pp. 10-14
39. Nussey, S.S., Whitehead, S.A., (2001) Endocrinology: an integrated approach, , London: Taylor & Francis
40. Mauras, N., Growth hormone and sex steroids: interactions in puberty (2001) Endocrinol Metab Clin North Am, 30 (3), pp. 529-544
41. Caufriez, A., The pubertal spurt: effects of sex steroids on growth hormone and insulin-like growth factor I (1997) Eur J Obstet Gynecol Reprod Biol, 71 (2), pp. 215-217
42. Sisk, C.L., Foster, D.L., The neural basis of puberty and adolescence (2004) Nat Neurosci, 7 (10), pp. 1040-1047
43. Norman, A.W., Litwack, G., Hormones in pregnancy and lactation (1987) Hormones, , London: Academic Press Inc
44. Singh, R.R., Kumar, R., Steroid hormone receptor signaling in tumorigenesis (2005) J Cell Biochem, 96 (3), pp. 490-505
45. Missmer, S., Eliassen, A., Barbieri, R., Hankinson, S., Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women (2004) J Natl Cancer Inst, 96 (24), pp. 1856-1865
46. Pike, M., Spicer, D., Dahmoush, L., Press, M., Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk (1993) Epidemiol Rev, 15 (1), pp. 17-35
47. Girling, J.S., Whitaker, H.C., Mills, I.G., Neal, D.E., Pathogenesis of prostate cancer and hormone refractory prostate cancer (2007) Indian J Urol, 23 (1), pp. 35-42
48. Carroll, R.S., Zhang, J., Dashner, K., Sar, M., Black, P.M.L., Steroid hormone receptors in astrocytic neoplasms (1995) Neurosurgery, 37 (3), pp. 496-503
49. Wigertz, A., Lonn, S., Mathiesen, T., Ahlbom, A., Hall, P., Feychting, M., Risk of brain tumors associated with exposure to exogenous female sex hormones (2006) Am J Epidemiol, 164 (7), pp. 629-636
50. Wahab, M., Al-Azzawi, F., Meningioma and hormonal influences (2003) Climacteric, 6 (4), pp. 285-292
51. Concolino, G., Liccardo, G., Conti, C., Panfili, C., Giuffre, R., Hormones and tumours in central nervous system (CNS): steroid receptors in primary spinal cord tumours (1984) Neurol Res, 6 (3), pp. 121-126
52. Concolino, G., Giuffr, R., Margiotta, G., Liccardo, G., Marocchi, A., Steroid receptors in CNS: estradiol (ER) and progesterone (PR) receptors in human spinal cord tumors (1984) J Steroid Biochem, 20 (1), pp. 491-494
53. Martuza, R.L., MacLaughlin, D.T., Ojemann, R.G., Specific estradiol binding in schwannomas, meningiomas, and neurofibromas (1981) Neurosurgery, 9 (6), p. 665
54. Chaudhuri, P.K., Walker, M.J., Gupta, T.K.D., Beattie, C.W., Steroid receptors in tumors of nerve sheath origin (1982) J Surg Oncol, 20 (4), pp. 205-206
55. McLaughlin, M.E., Jacks, T., Progesterone receptor expression in neurofibromas (2003) Cancer Res, 63 (4), p. 752
56. Geller, M., Mezitis, S.G.E., Nunes, F.P., Ribeiro, M.G., de Araú, Q.C., Jo, A.P., Bronstein, M.D., Cunha, K.S.G., Progesterone and estrogen receptors in neurofibromas of patients with NF1 (2008) Clin Med: Pathol, 1, pp. 93-97
57. Sonestedt, E., Ivarsson, M., Harlid, S., Ericson, U., Gullberg, B., Carlson, J., Olsson, H., Wirfalt, E., The Protective Association of High Plasma Enterolactone with Breast Cancer Is Reasonably Robust in Women with Polymorphisms in the Estrogen Receptor {alpha} and {beta} Genes (2009) J Nutr, 139 (5), p. 993
58. Roth, T.M., Ramamurthy, P., Muir, D., Wallace, M.R., Zhu, Y., Chang, L., Barald, K.F., Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin (2008) Dev Dyn, 237 (2), pp. 513-524
59. Berthois, Y., Katzenellenbogen, J., Katzenellenbogen, B., Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture (1986) Proc Natl Acad Sci U S A, 83 (8), pp. 2496-2500
60. Hull, K.L., Harvey, S., Growth hormone: roles in female reproduction (2001) J Endocrinol, 168 (1), pp. 1-23
61. Billestrup, N., Hansen, J., Møldrup, A., Galsgaard, E., Nielsen, J., Molecular mechanism of growth hormone signalling (1998) Endocr J, 45, pp. S41-S45
62. Carter-Su, C., Rui, L., Stofega, M.R., SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone (2000) Recent Prog Horm Res, 55, pp. 293-311
63. Alexander, L., Appleton, D., Hall, R., Ross, W.M., Wilkinson, R., Epidemiology of acromegaly in the Newcastle region (1980) Clin Endocr, 12 (1), pp. 71-79
64. Bengtsson, B., Edén, S., Ernest, I., Odén, A., Sjögren, B., Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984 (1988) Acta Med Scand, 223 (4), pp. 327-335
65. Barzilay, J., Heatley, G.J., Cushing, G.W., Benign and malignant tumors in patients with acromegaly (1991) Arch Intern Med, 151 (8), pp. 1629-1632
66. Ratner, R., Hare, J., Association of acromegaly and chondrosarcoma (1983) South Med, 76 (9), pp. 1181-1182
67. Aktan, M., Tanakol, R., Nalcaci, M., Dincol, G., Leukemia in a patient treated with growth hormone (2000) Endocr J, 47 (4), pp. 471-474
68. Watanabe, S., Mizuno, S., Oshima, L.H., Tsunematsu, Y., Fujimoto, J., Komiyama, A., Leukemia and other malignancies among GH users J Pediat Endocrinol, 6 (1), pp. 99-108
69. Emerman, J.T., Leahy, M., Gout, P.W., Bruchovsky, N., Elevated growth hormone levels in sera from breast cancer patients (1985) Horm Metab Res, 17 (8), pp. 421-424
70. Andrews, G.S., Growth hormone and malignancy (1983) J Clin Pathol, 36 (8), pp. 935-937
71. Group, B.P.S., Evaluation of plasma hormone concentrations in relation to clinical staging in patients with prostatic cancer (1979) Br J Urol, 51, pp. 382-389
72. Friedrich, R., Keiner, D., Hagel, C., Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1 (2007) Anticancer Res, 27 (4 A), pp. 2085-2090
73. Hansson, H.A., Lauritzen, C., Lossing, C., Petruson, K., Somatomedin C as tentative pathogenic factor in neurofibromatosis (1988) Scand J Plast Reconstr Surg Hand Surg, 22 (1), pp. 7-13
74. Cunha, K.S.G., Barboza, E.P., Fonseca, E.C.D., Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1 (2003) J Clin Pathol, 56 (10), pp. 758-763
75. Cunha, K.S.G.C., Barboza, E.P., Fonseca, E.C.D., Identification of growth hormone receptor in plexiform neurofibromas of patients with neurofibromatosis type 1 (2008) Clinics (Sao Paulo), 63 (1), pp. 39-42
76. Riccardi, V.M., The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1 (2007) Neurosurg Focus, 22 (6), pp. E3
77. Lammert, M., Mautner, V., Kluwe, L., Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients (2005) BMC Cancer, 5, p. 16
78. Saenger, P., Growth hormone in von Recklinghausen's disease: reckless or recommended? (1998) J Pediatr, 133 (2), pp. 172-174
79. Howell, S.J., Wilton, P., Lindberg, A., Shalet, S.M., Growth hormone replacement and the risk of malignancy in children with neurofibromatosis (1998) J Pediatr, 133 (2), pp. 201-205
80. Howell, S.J., Wilton, P., Lindberg, A., Shalet, S.M., Growth hormone and neurofibromatosis (2000) Hormone Res, 53 (1), pp. 70-76